Chronic coronary syndrome
Conditions
Interventions
CRSWD group:None
Sponsors
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.Age between 18 and 85 years old, no gender limitation ; 2.Patients have certain language expression and understanding ability, understand and voluntarily fill in the informed consent form, cooperate with the completion of blood tests, and can complete the sleep log and other scales; 3.Satisfy one of seven conditions: 1) Patients with suspected coronary heart disease and symptoms of stable angina pectoris, regardless of whether they have dyspnea; 2) Patients with newly developed heart failure or left ventricular dysfunction and suspected coronary heart disease; 3) Asymptomatic or stable patients after acute coronary syndrome; 4) Patients with or without symptoms, more than 1 year after initial diagnosis or revascularization; 5) Patients with angina pectoris and suspected vasospasm or microcirculation disease; 6) Asymptomatic patients with coronary heart disease were found during screening; 7) Patients admitted to hospital due to chest tightness and palpitation were examined and excluded from organic heart disease.
Exclusion criteria
Exclusion criteria: 1.Acute coronary syndrome, or within 1 month after percutaneous coronary intervention (PCI), or within 3 months after coronary artery bypass grafting (CABG); 2.Patients with non-coronary artery diseases that seriously affect cardiac function, such as severe valve regitation, artificial heart valve replacement, congenital heart disease, severe ventricular arrhythmia, atrial fibrillation, and NYHA Class IV serious heart disease; 3.Patients with serious non-cardiovascular diseases or diseases affecting the life expectancy of patients, such as history of connective tissue diseases, malignant tumors, organ failure caused by various reasons, severe immune system diseases, or combined with liver, kidney, hematopoietic system and other serious primary diseases, acute infectious diseases, mental disorders; 4.The patient could not cooperate to complete the scale assessment and blood test; 5.Women during pregnancy; 6.Taking drugs with definite cardiotoxicity, such as anthracyclines; 7.The attending physician or researcher considers that there are other circumstances that are not suitable for participation in this study; 8.Patients have participated in other clinical trials;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seattle Angina Scale;Stable Angina Severity Scale (CCS scale);Sleep-wake rhythms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate variability;SF-36 Quality of Life Scale;Coronary heart disease stable angina syndrome element score; | — |
Countries
China
Contacts
Public ContactLi Xiao
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Outcome results
None listed